These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31785831)

  • 1. CELLTOP Clinical Trial: First Report From a Phase 1 Trial of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in the Treatment of Paralysis Due to Traumatic Spinal Cord Injury.
    Bydon M; Dietz AB; Goncalves S; Moinuddin FM; Alvi MA; Goyal A; Yolcu Y; Hunt CL; Garlanger KL; Del Fabro AS; Reeves RK; Terzic A; Windebank AJ; Qu W
    Mayo Clin Proc; 2020 Feb; 95(2):406-414. PubMed ID: 31785831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury: Phase I trial.
    Bydon M; Qu W; Moinuddin FM; Hunt CL; Garlanger KL; Reeves RK; Windebank AJ; Zhao KD; Jarrah R; Trammell BC; El Sammak S; Michalopoulos GD; Katsos K; Graepel SP; Seidel-Miller KL; Beck LA; Laughlin RS; Dietz AB
    Nat Commun; 2024 Apr; 15(1):2201. PubMed ID: 38561341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal transplantation of autologous adipose-derived mesenchymal stem cells for treating spinal cord injury: A human trial.
    Hur JW; Cho TH; Park DH; Lee JB; Park JY; Chung YG
    J Spinal Cord Med; 2016 Nov; 39(6):655-664. PubMed ID: 26208177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous infusion of auto serum-expanded autologous mesenchymal stem cells in spinal cord injury patients: 13 case series.
    Honmou O; Yamashita T; Morita T; Oshigiri T; Hirota R; Iyama S; Kato J; Sasaki Y; Ishiai S; Ito YM; Namioka A; Namioka T; Nakazaki M; Kataoka-Sasaki Y; Onodera R; Oka S; Sasaki M; Waxman SG; Kocsis JD
    Clin Neurol Neurosurg; 2021 Apr; 203():106565. PubMed ID: 33667953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomes.
    Oraee-Yazdani S; Akhlaghpasand M; Golmohammadi M; Hafizi M; Zomorrod MS; Kabir NM; Oraee-Yazdani M; Ashrafi F; Zali A; Soleimani M
    Stem Cell Res Ther; 2021 Aug; 12(1):445. PubMed ID: 34372939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury.
    Mendonça MV; Larocca TF; de Freitas Souza BS; Villarreal CF; Silva LF; Matos AC; Novaes MA; Bahia CM; de Oliveira Melo Martinez AC; Kaneto CM; Furtado SB; Sampaio GP; Soares MB; dos Santos RR
    Stem Cell Res Ther; 2014 Nov; 5(6):126. PubMed ID: 25406723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study.
    Albu S; Kumru H; Coll R; Vives J; Vallés M; Benito-Penalva J; Rodríguez L; Codinach M; Hernández J; Navarro X; Vidal J
    Cytotherapy; 2021 Feb; 23(2):146-156. PubMed ID: 32981857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury.
    Takahashi A; Nakajima H; Uchida K; Takeura N; Honjoh K; Watanabe S; Kitade M; Kokubo Y; Johnson WEB; Matsumine A
    Cell Transplant; 2018 Jul; 27(7):1126-1139. PubMed ID: 29947256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic spinal cord injury treated with transplanted autologous bone marrow-derived mesenchymal stem cells tracked by magnetic resonance imaging: a case report.
    Chotivichit A; Ruangchainikom M; Chiewvit P; Wongkajornsilp A; Sujirattanawimol K
    J Med Case Rep; 2015 Apr; 9():79. PubMed ID: 25885347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and potential effects of intrathecal injection of allogeneic human umbilical cord mesenchymal stem cell-derived exosomes in complete subacute spinal cord injury: a first-in-human, single-arm, open-label, phase I clinical trial.
    Akhlaghpasand M; Tavanaei R; Hosseinpoor M; Yazdani KO; Soleimani A; Zoshk MY; Soleimani M; Chamanara M; Ghorbani M; Deylami M; Zali A; Heidari R; Oraee-Yazdani S
    Stem Cell Res Ther; 2024 Aug; 15(1):264. PubMed ID: 39183334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase III Clinical Trial Showing Limited Efficacy of Autologous Mesenchymal Stem Cell Therapy for Spinal Cord Injury.
    Oh SK; Choi KH; Yoo JY; Kim DY; Kim SJ; Jeon SR
    Neurosurgery; 2016 Mar; 78(3):436-47; discussion 447. PubMed ID: 26891377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image-guided percutaneous intralesional administration of mesenchymal stromal cells in subjects with chronic complete spinal cord injury: a pilot study.
    Larocca TF; Macêdo CT; Souza BSF; Andrade-Souza YM; Villarreal CF; Matos AC; Silva DN; da Silva KN; de Souza CLEM; Paixão DDS; Bezerra MDR; Alves RL; Soares MBP; Dos Santos RR
    Cytotherapy; 2017 Oct; 19(10):1189-1196. PubMed ID: 28760352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant and anti-inflammatory effects of intravenously injected adipose derived mesenchymal stem cells in dogs with acute spinal cord injury.
    Kim Y; Jo SH; Kim WH; Kweon OK
    Stem Cell Res Ther; 2015 Nov; 6():229. PubMed ID: 26612085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous mesenchymal stromal cell transplantation for spinal cord injury: A Phase I pilot study.
    Satti HS; Waheed A; Ahmed P; Ahmed K; Akram Z; Aziz T; Satti TM; Shahbaz N; Khan MA; Malik SA
    Cytotherapy; 2016 Apr; 18(4):518-22. PubMed ID: 26971680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and potential efficacy of expanded mesenchymal stromal cells of bone marrow and umbilical cord origins in patients with chronic spinal cord injuries: a phase I/II study.
    Awidi A; Al Shudifat A; El Adwan N; Alqudah M; Jamali F; Nazer F; Sroji H; Ahmad H; Al-Quzaa N; Jafar H
    Cytotherapy; 2024 Aug; 26(8):825-831. PubMed ID: 38703153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-transplantation of autologous bone marrow mesenchymal stem cells and Schwann cells through cerebral spinal fluid for the treatment of patients with chronic spinal cord injury: safety and possible outcome.
    Oraee-Yazdani S; Hafizi M; Atashi A; Ashrafi F; Seddighi AS; Hashemi SM; Seddighi A; Soleimani M; Zali A
    Spinal Cord; 2016 Feb; 54(2):102-9. PubMed ID: 26526896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of mesenchymal stem cells for spinal cord injury: a systematic review and network meta-analysis.
    Chen WC; Liu WF; Bai YY; Zhou YY; Zhang Y; Wang CM; Lin S; He HF
    J Transl Med; 2021 Apr; 19(1):178. PubMed ID: 33910588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated subarachnoid administrations of allogeneic human umbilical cord mesenchymal stem cells for spinal cord injury: a phase 1/2 pilot study.
    Yang Y; Pang M; Du C; Liu ZY; Chen ZH; Wang NX; Zhang LM; Chen YY; Mo J; Dong JW; Xie PG; Wang QY; Liu B; Rong LM
    Cytotherapy; 2021 Jan; 23(1):57-64. PubMed ID: 33218835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: Safety and efficacy of the 100/3 guideline.
    Vaquero J; Zurita M; Rico MA; Aguayo C; Bonilla C; Marin E; Tapiador N; Sevilla M; Vazquez D; Carballido J; Fernandez C; Rodriguez-Boto G; Ovejero M;
    Cytotherapy; 2018 Jun; 20(6):806-819. PubMed ID: 29853256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Mesenchymal Stem Cells for Spinal Cord Injury.
    Alishahi M; Anbiyaiee A; Farzaneh M; Khoshnam SE
    Curr Stem Cell Res Ther; 2020; 15(4):340-348. PubMed ID: 32178619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.